ChinaDaily Briefs

Daily Brief China: Shanghai Henlius Biotech , Ping An Healthcare and Technology, Cambricon Technologies Lt, CNY, Tencent, Hang Seng Index, Sunac China Holdings, Freetech Intelligent Systems, Longfor Properties and more

In today’s briefing:

  • Henlius (2696 HK): Test of Nerves Awaiting LVC’s Next Move
  • Ping An Healthcare and Technology (1833.HK) – Thoughts About The Mandatory General Offer and Outlook
  • STAR Chip Index Rebalance Preview: Changes in March
  • The Week Ahead – CPI, China, and Currencies
  • EQD | Hong Kong Single Stock Options Weekly January 06 – 10
  • EQD | Hong Kong Index Options Weekly – HSI and HSCEI January 06 – 10
  • Asia Real Estate Tracker (12-Jan-2025): Sunac unable to repay debt on time due to new petition.
  • Freetech Zhejiang Intelligent Technology Pre-IPO
  • Lucror Analytics – Morning Views Asia


Henlius (2696 HK): Test of Nerves Awaiting LVC’s Next Move

By Arun George

  • The vote on Fosun Pharma’s HK$24.60 offer for Shanghai Henlius Biotech (2696 HK) is on 22 January. The gross spread ballooned today due to LVC’s amassing a blocking stake.
  • There are valid arguments for LVC to block the vote or to support the offer. LVC’s trading behaviour over the coming days will point to its voting intentions. 
  • I continue to believe that LVC will support the offer. At the current price and for a 15 February payment, the gross/annualised spread is 9.1%/160%.

Ping An Healthcare and Technology (1833.HK) – Thoughts About The Mandatory General Offer and Outlook

By Xinyao (Criss) Wang

  • Through Special Dividend, Ping An has achieved its initial plan at a low price. Ping An ruled out the possibility of privatization, which could be due to the high cost.
  • Ping An may hope to further leverage the synergies, increase resource tilt towards PAGD, thereby helping it out of the trough.But we’re not optimistic due to PAGD’s problematic business model.
  • The gap between PAGD and JD Health/Alibaba Health will continue to widen. Based on our forecast, we think PAGD is overvalued. Its valuation should be lower than JD Health/Alibaba Health.

STAR Chip Index Rebalance Preview: Changes in March

By Brian Freitas

  • There could be 1 constituent change for the STAR Chip Index at the March rebalance. There will also be a few capping changes.
  • Estimated one-way turnover is 6.5% resulting in a round-trip trade of CNY 3.12bn (US$426m). Passives need to trade between 0.24-0.33x ADV in the potential changes.
  • There is one very close add and the final list could change depending on price performance over the next 10 trading days.

The Week Ahead – CPI, China, and Currencies

By Nomura – The Week Ahead

  • Trump plans to put serious tariffs on Mexico and Canada due to immigration and drug issues, impacting Asian currencies
  • US and UK CPI data in focus for the week ahead, with expectations of higher inflation
  • Currency depreciation pressures in Asia expected to continue, with China and Korea most vulnerable to depreciation pressures

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


EQD | Hong Kong Single Stock Options Weekly January 06 – 10

By John Ley

  • Tough week with 82% of optionable stocks we survey declining on the week but no sign of panic as investors still prefer Calls over Puts. 
  • Tencent was far and away the volume leader, accounting for 37% of all option trading.
  • Materials was the only Sector to see price gains and implied vol rose across all Sectors we survey.

EQD | Hong Kong Index Options Weekly – HSI and HSCEI January 06 – 10

By John Ley

  • HSI and HSCEI were down every day this past week.
  • HSI total Put volume heavier than total Call volume on the two largest down days this week showing rising concern amongst investors.
  • Having dropped 5.6% to start the year HSI has already moved well past the implied move at the start of the month.

Asia Real Estate Tracker (12-Jan-2025): Sunac unable to repay debt on time due to new petition.

By Asia Real Estate Tracker

  • Sunac faces financial distress as China Cinda files new wind-up petition due to inability to repay debt.
  • Country Garden plans to reduce $11.6B offshore debt as home sales decline in current market conditions.
  • UOL from Singapore successfully invests $285M in Sydney office amid market revival, showcasing confidence in growth.

Freetech Zhejiang Intelligent Technology Pre-IPO

By Nicholas Tan

  • Freetech Intelligent Systems (1901036D CH) is looking to raise up to US$200m in its upcoming Hong Kong IPO.
  • The firm is a leading intelligent driving solutions provider, covering advanced assistance system (ADAS) and autonomous driving system (ADS) technologies.
  • In this note, we look at the firm’s past performance.

Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Longfor Group, Logan Group, Vedanta Resources, Sunny Optical
  • In the US, the December 2024 nonfarm payrolls unexpectedly jumped to 256 k (165 k e / 212 k revised p), with November’s data adjusted downwards by 15 k. Average hourly earnings edged down to 0.3% m-o-m (0.3% e / 0.4% p) and 3.9% y-o-y (4.0% e / 4.0% p), while the unemployment rate declined to 4.1% (4.2% e / 4.2% p).
  • Separately, the January 2025 (preliminary) University of Michigan consumer sentiment index fell to 73.2 (74.0 e / 74.0 p). The one-year inflation expectation among consumers soared to 3.3% (2.8% e / 2.8% p), the highest since May 2024 and above the 2.3-3.0% range seen in the two years prior to the COVID-19 pandemic.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars